{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:21:02Z","timestamp":1777422062161,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":6464,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1038\/modpathol.3800360","type":"journal-article","created":{"date-parts":[[2005,2,4]],"date-time":"2005-02-04T14:35:23Z","timestamp":1107527723000},"page":"615-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Laura C","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J","family":"Schnitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.3800360_bib1","series-title":"Ductal Carcinoma In Situ of the Breast,","first-page":"37","article-title":"Biologic characteristics of ductal carcinoma in situ","author":"Allred","year":"2002"},{"key":"10.1038\/modpathol.3800360_bib2","series-title":"Ductal Carcinoma In Situ of the Breast,","first-page":"49","article-title":"Prognostic factors in ductal carcinoma in situ","author":"Ravdin","year":"2002"},{"key":"10.1038\/modpathol.3800360_bib3","series-title":"Ductal Carcinoma In Situ of the Breast","first-page":"234","article-title":"Angiogenesis in ductal carcinoma in situ of the breast","author":"Schnitt","year":"2002"},{"key":"10.1038\/modpathol.3800360_bib4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMra031301","article-title":"Ductal carcinoma in situ of the breast","volume":"350","author":"Burstein","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.3800360_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jnci\/djh164","article-title":"Ductal carcinoma in situ, complexities and challenges","volume":"96","author":"Leonard","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.3800360_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2559.1989.tb01623.x","article-title":"Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study","volume":"15","author":"Giri","year":"1989","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.3800360_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/ajcp\/94.5.533","article-title":"Potential value of hormone receptor assay in carcinoma in situ of breast","volume":"94","author":"Barnes","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.3800360_bib8","first-page":"2113","article-title":"Receptors for estrogen and progesterone in breast carcinoma in situ","volume":"12","author":"Pallis","year":"1992","journal-title":"Anticancer Res"},{"key":"10.1038\/modpathol.3800360_bib9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/cncr.2820690518","article-title":"Estrogen receptor immunohistochemistry in carcinoma in situ of the breast","volume":"69","author":"Bur","year":"1992","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800360_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/bjc.1993.305","article-title":"Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein","volume":"68","author":"Poller","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3800360_bib11","first-page":"134","article-title":"Distribution of estrogen receptor in ductal carcinoma in situ of the breast","volume":"113","author":"Chaudhuri","year":"1993","journal-title":"Surgery"},{"key":"10.1038\/modpathol.3800360_bib12","first-page":"114","article-title":"Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study","volume":"6","author":"Wilbur","year":"1993","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.3800360_bib13","first-page":"208","article-title":"Mammographically detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity","volume":"11","author":"Zafrani","year":"1994","journal-title":"Semin Diagn Pathol"},{"key":"10.1038\/modpathol.3800360_bib14","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/1097-0142(19950415)75:8<2123::AID-CNCR2820750815>3.0.CO;2-V","article-title":"Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein","volume":"75","author":"Leal","year":"1995","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800360_bib15","first-page":"81","article-title":"Immunophenotype of intraductal carcinoma","volume":"120","author":"Bose","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.3800360_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0748-7983(96)92242-8","article-title":"Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast","volume":"22","author":"Karayiannakis","year":"1996","journal-title":"Eur J Surg Oncol"},{"key":"10.1038\/modpathol.3800360_bib17","first-page":"1088","article-title":"Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers","volume":"10","author":"Moreno","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.3800360_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0959-8049(96)00368-1","article-title":"p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast","volume":"33","author":"Rudas","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.3800360_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2559.1998.00505.x","article-title":"Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins","volume":"33","author":"Quinn","year":"1998","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.3800360_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1525-1500.1998.CDOA41.x","article-title":"Biological profile of in situ breast cancer investigated by immunohistochemical technique","volume":"22","author":"Albonico","year":"1998","journal-title":"Cancer Detect Prev"},{"key":"10.1038\/modpathol.3800360_bib21","first-page":"108","article-title":"Ductal carcinoma in situ of the breast: frequency of biomarkers according to histologic type","volume":"7","author":"Bhoola","year":"1999","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.3800360_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<237::AID-PATH343>3.0.CO;2-8","article-title":"Oestrogen receptor expression in the normal and pre-cancerous breast","volume":"188","author":"Shoker","year":"1999","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.3800360_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exmp.2001.2366","article-title":"Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2\/neu and hormone receptors","volume":"70","author":"Claus","year":"2001","journal-title":"Exp Mol Pathol"},{"key":"10.1038\/modpathol.3800360_bib24","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(01)00165-4","article-title":"Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics","volume":"37","author":"Ringberg","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.3800360_bib25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0959-8049(02)00666-4","article-title":"Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast","volume":"39","author":"Provenzano","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.3800360_bib26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/cncr.11204","article-title":"Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women","volume":"97","author":"Rodrigues","year":"2003","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800360_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/bjc.1988.238","article-title":"An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma","volume":"58","author":"Barnes","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3800360_bib28","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJM198811103191902","article-title":"Neu-protein overexpression in breast cancer. Association with comedo- type ductal carcinoma in situ and limited prognostic value in stage II breast cancer","volume":"319","author":"van de Vijver","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.3800360_bib29","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/0046-8177(90)90154-W","article-title":"Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ","volume":"21","author":"Bartkova","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3800360_bib30","first-page":"449","article-title":"Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast","volume":"3","author":"Lodato","year":"1990","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.3800360_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.1711610104","article-title":"Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma\u2014a detailed morphological analysis","volume":"161","author":"Ramachandra","year":"1990","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.3800360_bib32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0959-8049(05)80117-0","article-title":"Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?","volume":"28","author":"Barnes","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.3800360_bib33","first-page":"S48","article-title":"Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ","volume":"97","author":"Schimmelpenning","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.3800360_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jcp.45.1.16","article-title":"c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma","volume":"45","author":"Somerville","year":"1992","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.3800360_bib35","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0046-8177(92)90257-4","article-title":"Overexpression of HER-2\/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer","volume":"23","author":"Allred","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3800360_bib36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1349-7006.1993.tb00149.x","article-title":"p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade","volume":"84","author":"Tsuda","year":"1993","journal-title":"Jpn J Cancer Res"},{"key":"10.1038\/modpathol.3800360_bib37","first-page":"199","article-title":"The classification of ductal carcinoma in situ and its association with biological markers","volume":"11","author":"Bobrow","year":"1994","journal-title":"Semin Diagn Pathol"},{"key":"10.1038\/modpathol.3800360_bib38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0046-8177(95)90163-9","article-title":"neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast","volume":"26","author":"De Potter","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3800360_bib39","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0046-8177(97)90014-9","article-title":"Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67","volume":"28","author":"Mack","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3800360_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5858\/2000-124-0234-PEATEI","article-title":"p53, ErbB2, and TAG-72 expression in the spectrum of ductal carcinoma in situ of the breast classified by the Van Nuys system","volume":"124","author":"Kanthan","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.3800360_bib41","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/1097-0142(20001201)89:11<2153::AID-CNCR2>3.0.CO;2-O","article-title":"In microdissected ductal carcinoma in situ, HER-2\/neu amplification, but not p53 mutation, is associated with high nuclear grade and comedo histology","volume":"89","author":"Ho","year":"2000","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800360_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1006453420088","article-title":"Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy","volume":"60","author":"Ottesen","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.3800360_bib43","first-page":"6667","article-title":"Active signaling by HER-2\/neu in a subpopulation of HER-2\/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates","volume":"62","author":"DiGiovanna","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3800360_bib44","series-title":"Ductal Carcinoma In Situ of the Breast,","first-page":"54","article-title":"HER-2\/neu gene amplification and overexpression in ductal carcinoma in situ","author":"Schmitt","year":"2002"},{"key":"10.1038\/modpathol.3800360_bib45","first-page":"S36","article-title":"Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: findings from NSABP Protocol B-24","volume":"76","author":"Allred","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.3800360_bib46","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1200\/JCO.1996.14.10.2702","article-title":"c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases","volume":"14","author":"Carlomagno","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800360_bib47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1200\/JCO.1998.16.2.462","article-title":"Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers","volume":"16","author":"Sjogren","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800360_bib48","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2001.19.8.2334","article-title":"When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer","volume":"19","author":"Yamauchi","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800360_bib49","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1200\/JCO.2001.19.18.3808","article-title":"Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and\/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial","volume":"19","author":"Ellis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800360_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jnci\/95.5.353","article-title":"Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2\/neu in tamoxifen resistance in breast cancer","volume":"95","author":"Osborne","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.3800360_bib51","first-page":"1039","article-title":"Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer","volume":"9","author":"De Placido","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.3800360_bib52","first-page":"S6","article-title":"Comparison of anastrazole vs tamoxifen alone and in combination as neoadjuvant treatment of estrogen receptor-positive operable breast cancer in post-menopausal women: the IMPACT trial","volume":"82","author":"Smith","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.3800360_bib53","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnci\/djh166","article-title":"Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2\/neu cross-talk in ER\/HER2-positive breast cancer","volume":"96","author":"Shou","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.3800360_bib54","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jnci\/djh191","article-title":"Tamoxifen: Dr. Jekyll and Mr. Hyde?","volume":"96","author":"Hayes","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.3800360_bib55","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0039-6109(16)45185-6","article-title":"Duct carcinoma in situ. Pathology and treatment","volume":"70","author":"Lagios","year":"1990","journal-title":"Surg Clin North Am"},{"key":"10.1038\/modpathol.3800360_bib56","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800360_bib57","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1200\/JCO.2000.18.20.3471","article-title":"HER-2\/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer","volume":"18","author":"Berry","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3800360_bib58","first-page":"7","article-title":"HER-2 expression and response to tamoxifen in estrogen receptor- positive breast cancer: a Southwest Oncology Group Study","volume":"4","author":"Elledge","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.3800360_bib59","first-page":"8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3800360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800360","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222046336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222046336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:21:06Z","timestamp":1760232066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222046336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0893395222046336"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.3800360","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3800360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}